Tuomas T Rissanen Selected Research

Tuomas T Rissanen Research Topics

6	Myocardial Infarction 09/2023 - 11/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2023 - 01/2019
5	Hemorrhage 01/2023 - 04/2017
5	Ischemia 04/2017 - 04/2002
3	Coronary Disease (Coronary Heart Disease) 11/2018 - 02/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2022 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 11/2013
2	Acute Coronary Syndrome 01/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2019 - 12/2016
2	Hypoxia (Hypoxemia) 05/2004 - 04/2002
2	Atherosclerosis 10/2003 - 11/2002
1	Pathologic Constriction (Stenosis) 11/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Sudden Death 01/2021
1	Death (Near-Death Experience) 01/2021
1	Atrial Flutter (Flutter, Atrial) 12/2019
1	Tachycardia (Tachyarrhythmias) 12/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Hemangioma (Angioma) 10/2014
1	Heart Failure 11/2013
1	Infarction (Infarctions) 11/2013
1	Coronary Occlusion 11/2013
1	Retinal Neovascularization 04/2009
1	Pathologic Neovascularization 04/2009
1	Inflammation (Inflammations) 05/2004
1	Hyperplasia 03/2004
1	Neointima 03/2004
1	Edema (Dropsy) 01/2004
1	Pericardial Effusion 01/2004
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2003
1	Atherosclerotic Plaque (Atheroma) 11/2002

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2004 - 04/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2019
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2004 - 04/2002
2	LipidsIBA 09/2023 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2023 - 08/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2017
2	MetalsIBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 05/2004 - 11/2002
1	Lipoproteins (Lipoprotein)IBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	CholesterolIBA 09/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	LDL CholesterolIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	AnticoagulantsIBA 04/2017
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2013
1	Vascular Endothelial Growth Factor BIBA 04/2009
1	Therapeutic UsesIBA 03/2007
1	Vascular Endothelial Growth FactorsIBA 03/2007
1	A-Form DNA (A-DNA)IBA 05/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2004
1	Platelet-Derived Growth FactorIBA 03/2004
1	Vascular Endothelial Growth Factor CIBA 03/2004
1	LigandsIBA 03/2004
1	Vascular Endothelial Growth Factor DIBA 10/2003
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2003
1	Fibroblast Growth Factor 4IBA 01/2003
1	MitogensIBA 04/2002

5	Percutaneous Coronary Intervention 02/2023 - 01/2019
5	Therapeutics 01/2018 - 05/2004
4	Stents 01/2020 - 11/2013
3	Surgical Amputation (Amputations) 05/2004 - 04/2002
2	Secondary Prevention 01/2020 - 11/2018
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Drug-Eluting Stents 01/2020
1	Cardiac Resynchronization Therapy Devices 12/2019
1	Defibrillators (Defibrillator) 01/2018